MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A von Sun, T, Wang, X, He, H H, Sweeney, C J, Liu, S X, Brown, M, Balk, S, Lee, G-SM, Kantoff, P W

Volltext

Ramsay Hunt syndrome von Sweeney, C J, Gilden, D H

Volltext

Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer von Zheng, D, Gui, B, Gray, K P, Tinay, I, Rafiei, S, Huang, Q, Sweeney, C J, Kibel, A S, Jia, L

Volltext

Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer von Flanagan, J., Gray, P. Kathryn, Hahn, N., Hayes, J., Myers, L.J., Carney-Doebbeling, C., Sweeney, C.J.

Volltext

A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor von Ravi, P., Gray, K.P., O'Donnell, E.K., Sweeney, C.J.

Volltext

A Phase I Study of the Pharmacokinetic and Safety Profiles of Oral Pazopanib With a High-Fat or Low-Fat Meal in Patients With Advanced Solid Tumors von Heath, E I, Chiorean, E G, Sweeney, C J, Hodge, J P, Lager, J J, Forman, K, Malburg, L, Arumugham, T, Dar, M M, Suttle, A B, Gainer, S D, LoRusso, P

Volltext

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors von Jonker, D.J., Rosen, L.S., Sawyer, M.B., de Braud, F., Wilding, G., Sweeney, C.J., Jayson, G.C., McArthur, G.A., Rustin, G., Goss, G., Kantor, J., Velasquez, L., Syed, S., Mokliatchouk, O., Feltquate, D.M., Kollia, G., Nuyten, D.S.A., Galbraith, S.

Volltext

Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study von Kurzrock, R., Bowles, D.W., Kang, H., Meric-Bernstam, F., Hainsworth, J., Spigel, D.R., Bose, R., Burris, H., Sweeney, C.J., Beattie, M.S., Blotner, S., Schulze, K., Cuchelkar, V., Swanton, C.

Volltext

Redefining the Target: Chemotherapeutics as Antiangiogenics von MILLER, Kathy D, SWEENEY, Christopher J, SLEDGE, George W

Volltext

Field energetics and lung function in wild bottlenose dolphins, Tursiops truncatus, in Sarasota Bay Florida von Fahlman, A., Brodsky, M., Wells, R., McHugh, K., Allen, J., Barleycorn, A., Sweeney, J. C., Fauquier, D., Moore, M.

Volltext

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 von Gillessen, S., Omlin, A., Attard, G., de Bono, J.S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P.S., Sartor, O., Smith, M.R., Soule, H.R., Akaza, H., Beer, T.M., Beltran, H., Chinnaiyan, A.M., Daugaard, G., Davis, I.D., De Santis, M., Drake, C.G., Eeles, R.A., Fanti, S., Gleave, M.E., Heidenreich, A., Hussain, M., James, N.D., Lecouvet, F.E., Logothetis, C.J., Mastris, K., Nilsson, S., Oh, W.K., Olmos, D., Padhani, A.R., Parker, C., Rubin, M.A., Schalken, J.A., Scher, H.I., Sella, A., Shore, N.D., Small, E.J., Sternberg, C.N., Suzuki, H., Sweeney, C.J., Tannock, I.F., Tombal, B.

Volltext

Next generation radiotheranostics promoting precision medicine von Pomykala, K.L., Hadaschik, B.A., Sartor, O., Gillessen, S., Sweeney, C.J., Maughan, T., Hofman, M.S., Herrmann, K.

Volltext

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAART... von Hamid, A.A., Huang, H.-C., Wang, V., Chen, Y.-H., Feng, F., Den, R., Attard, G., Van Allen, E.M., Tran, P.T., Spratt, D.E., Dittamore, R., Davicioni, E., Liu, G., DiPaola, R., Carducci, M.A., Sweeney, C.J.

Volltext

What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis von Vale, C.L., Fisher, D.J., White, I.R., Carpenter, J.R., Burdett, S., Clarke, N.W., Fizazi, K., Gravis, G., James, N.D., Mason, M.D., Parmar, M.K.B., Rydzewska, L.H., Sweeney, C.J., Spears, M.R., Sydes, M.R., Tierney, J.F.

Volltext

Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer von Xie, W., Ravi, P., Buyse, M., Halabi, S., Kantoff, P., Sartor, O., Soule, H., Clarke, N., Dignam, J., James, N., Fizazi, K., Gillessen, S., Mottet, N., Murphy, L., Parulekar, W., Sandler, H., Tombal, B., Williams, S., Sweeney, C.J.

Volltext

Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients wit... von Chiorean, E.G., Hurwitz, H.I., Cohen, R.B., Schwartz, J.D., Dalal, R.P., Fox, F.E., Gao, L., Sweeney, C.J.

Volltext

A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67 von Hahn, N.M., Zon, R.T., Yu, M., Ademuyiwa, F.O., Jones, T., Dugan, W., Whalen, C., Shanmugam, R., Skaar, T., Sweeney, C.J.

Volltext

Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States von Mahal, B.A., Chen, Y.-W., Muralidhar, V., Mahal, A.R., Choueiri, T.K., Hoffman, K.E., Hu, J.C., Sweeney, C.J., Yu, J.B., Feng, F.Y., Kim, S.P., Beard, C.J., Martin, N.E., Trinh, Q.-D., Nguyen, P.L.

Volltext

A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion von Lago-Hernandez, C.A., Feldman, H., O'Donnell, E., Mahal, B.A., Perez, V., Howard, S., Rosenthal, M., Cheng, S.C., Nguyen, P.L., Beard, C., D'Amico, A.V., Sweeney, C.J.

Volltext

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas von Yip-Schneider, Michele T., Barnard, Darlene S., Billings, Steven D., Cheng, Liang, Heilman, Douglas K., Lin, Amy, Marshall, Steven J., Crowell, Pamela L., Marshall, Mark S., Sweeney, Christopher J.

Volltext